About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
Dr. Simmons explains the root causes of medical errors and discusses how academic health centers can create safer systems for patients by addressing potential errors and preventing their recurrence.
Richard L. Simmons, MD
Dr. Goldenberg presents a historical overview of women’s exclusion from and their recent inclusion in clinical drug trials.
Marvin M. Goldenberg, PhD, RPh, MS
The ACP promotes standards, advocates health and public policy, provides continuing education for internists, and emphasizes the importance of internal medicine to physicians and the public.
John Tooker, MD, MBA
Demonstrating the Business Value of Good Health: The Institute for Health and Productivity Management’s Academy
Vanja Sikirica, PharmD
Continuing Education Credit
The author reviews an illness that affects millions of patients and is the leading cause of liver failure, cirrhosis, and hepatocellular carcinoma.
Candice Nickens Frye, PharmD
Karl A. Matuszewski, MS, PharmD, discusses new “pay-for-performance” plans intended to improve the quality of health care.
Karl A. Matuszewski, MS, PharmD
Letter to the Editor
Nicole M. Cobb, Vittorio Maio, PharmD, MS, Jennifer H. Lofland, PharmD, MPH
Stephen Barlas discusses the need to “get tough” on drug compounders.
Matthew Grissinger, RPh, FASCP, explains the potential dangers from sharing eye drop containers.
Matthew Grissinger, RPh, FASCP
P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.
Gemifloxacin for the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis and Community-Acquired Pneumonia
The author reviews gemifloxacin (Factive®) for acute bacterial exacerbation of chronic bronchitis and community-acquired pneumonia.
Larisa Chagan, BS, PharmD